Family counseling improves lives of patients and spouses coping with prostate cancer

Key points
- Families coping with prostate cancer report improved quality of life from a structured support program integrated into the patient’s cancer management, according to a new study.
- Prostate cancer is the most frequently diagnosed cancer in men.
- These side effects have been shown to impact both the patient and his spouse, who is most often solely relied upon to provide support and home care.
- Northouse and her colleagues conducted a randomized control trial comparing standard patient-centered clinical care and an intensive multivariable intervention targeting patients and their spouses.
Families coping with prostate cancer report improved quality of life from a structured support program integrated into the patient’s cancer management, according to a new study. The findings appear in the December 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society. This randomized clinical trial by Dr. Laurel Northouse from the University of Michigan and co-investigators found that patients and their spouses who participated in a five-session home counseling program reported significant improvement in such areas as symptom management, hope, uncertainty and couples’ communication.
Prostate cancer is the most frequently diagnosed cancer in men. While treatment advances have reduced mortality rates since the early 1990s, the treatments themselves are often associated with serious permanent side effects, such as urinary incontinence or sexual dysfunction.
These side effects have been shown to impact both the patient and his spouse, who is most often solely relied upon to provide support and home care. Studies show that spouses of prostate cancer patients report greater levels of distress and uncertainty than their husbands and that couples report difficulties in communication. The stress of providing care for a loved one has been linked to poorer health and even higher risk of death.
Dr. Northouse and her colleagues conducted a randomized control trial comparing standard patient-centered clinical care and an intensive multivariable intervention targeting patients and their spouses. This family-based intervention targeted
1. so-called “appraisal variables” – that is appraisal of illness or caregiving, uncertainty, hopelessness
2. “coping resources” – such as coping strategies, self-efficacy, and communication
3. overall or cancer-specific “symptom distress” and
4. quality of life.
In Dr. Northouse’s clinical trial, 113 couples were assigned to the control group and 112 to the intervention. Couples in the intervention group received three 90-minute sessions at home and two follow-up telephone sessions over a four-month period. Couples were then assessed before treatment and every four months for one year.
Spouses in the intervention arm reported the most benefits and most sustained improvements “that improved spouses’ appraisal of the caregiving experience, increased their ability to cope, and enhanced their physical and mental quality of life.” For example, spouses in the intervention arm reported significantly better mental health by the fourth month and significantly improved physical quality of life by the eighth month.
Based on their findings, Dr. Northouse and co-authors conclude that by employing a structured and systematic program conducted “jointly with patients and spouses, clinicians can help both to gain information and obtain support, which reduces their uncertainty and facilitates communication about the illness.” At a minimum, they conclude, “clinicians need to recognize that spouses are affected by the cancer and to treat them as co-recipients of care.”
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsRare mutation may extend survival in lung cancer patients with brain metastases
New Haven, Conn. -Most patients with non-small cell lung cancer (NSCLC) that has metastasized to the brain have a dire prognosis. But Yale researchers have identified a subset of those patients with a rare genetic…
16 October 2015
NewsMulti-gene test enables some breast cancer patients to safely avoid chemotherapy
A major study published in the New England Journal of Medicine is providing the best evidence to date that a 21-gene test done on the tumor can identify breast cancer patients who can safely avoid chemotherapy.…
29 September 2015
NewsMolecular 'feedback loop' may explain tamoxifen resistance in patients with breast cancer
For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer cells still have the…






